Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor

Introduction A drug reaction with eosinophilia and systemic symptom (DRESS) is a severe and rare adverse-drug hypersensitivity syndrome. The evolution of DRESS is unpredictable and haematological abnormalities may occur in 50 % of cases. Sulfasalazine (SSZ) is rarely associated with DRESS. Agranuloc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical pharmacy 2015-08, Vol.37 (4), p.563-565
Hauptverfasser: Fathallah, Neila, Slim, Raoudha, Rached, Salaheddine, Hachfi, Wissem, Letaief, Amel, Ben Salem, Chaker
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction A drug reaction with eosinophilia and systemic symptom (DRESS) is a severe and rare adverse-drug hypersensitivity syndrome. The evolution of DRESS is unpredictable and haematological abnormalities may occur in 50 % of cases. Sulfasalazine (SSZ) is rarely associated with DRESS. Agranulocytosis is a rare but recognized side-effect to SSZ. Both DRESS and agranulocytosis were not reported previously with SSZ. Case summary We report a case of SSZ-induced DRESS followed by severe agranulocytosis occurring in a 25-year-old man. The patient’s general condition and laboratory tests gradually improved after the administration of granulocyte colony-stimulating factor (GCSF). Discussion In our patient, the co-occurrence of DRESS and agranulocytosis is unlikely to be coincidental. Immunological mechanisms may play an important role in drug associated agranulocytosis in patients presenting DRESS. According to the Naranjo’s algorithm the likelihood that our patient’s DRESS and agranulocytosis occurred as a result of therapy with SSZ is probable. G-CSF was found to be useful in shortening the duration of granulocyte recovery in drug-induced agranulocytosis. Conclusion Careful monitoring of neutrophil counts is required on SSZ therapy as well as in the course of DRESS.
ISSN:2210-7703
2210-7711
DOI:10.1007/s11096-015-0107-2